Parkside Financial Bank & Trust - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$392
-30.0%
4000.0%0.00%
Q2 2023$560
-49.7%
400
-42.9%
0.00%
Q1 2023$1,113
-55.3%
700
+75.0%
0.00%
-100.0%
Q4 2022$2,492
-16.9%
4000.0%0.00%0.0%
Q3 2022$3,0000.0%4000.0%0.00%0.0%
Q2 2022$3,000
+50.0%
4000.0%0.00%0.0%
Q1 2022$2,0000.0%4000.0%0.00%
Q4 2021$2,000
-60.0%
4000.0%0.00%
-100.0%
Q3 2021$5,000
-37.5%
4000.0%0.00%
-50.0%
Q2 2021$8,000
-27.3%
4000.0%0.00%
-33.3%
Q1 2021$11,000
+10.0%
4000.0%0.00%0.0%
Q4 2020$10,000
-33.3%
4000.0%0.00%
-40.0%
Q3 2020$15,000
-28.6%
4000.0%0.01%
-28.6%
Q2 2020$21,000
+61.5%
4000.0%0.01%
+40.0%
Q1 2020$13,000
-56.7%
400
-20.0%
0.01%
-44.4%
Q4 2019$30,000
+66.7%
5000.0%0.01%
+50.0%
Q3 2019$18,000
-21.7%
5000.0%0.01%
-14.3%
Q2 2019$23,000
+15.0%
5000.0%0.01%0.0%
Q1 2019$20,000
-13.0%
5000.0%0.01%
-12.5%
Q4 2018$23,000
+4.5%
5000.0%0.01%0.0%
Q3 2018$22,000
+10.0%
5000.0%0.01%
+14.3%
Q2 2018$20,000
-44.4%
5000.0%0.01%
-50.0%
Q1 2018$36,000
-39.0%
500
-44.4%
0.01%
-36.4%
Q4 2017$59,000
+31.1%
9000.0%0.02%
+22.2%
Q3 2017$45,000
+7.1%
9000.0%0.02%
+5.9%
Q2 2017$42,0009000.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders